Immunotherapy for metastatic renal cell carcinoma

BACKGROUND: Since the mid‐2000s, the field of metastatic renal cell carcinoma (mRCC) has experienced a paradigm shift from non‐specific therapy with broad‐acting cytokines to specific regimens, which directly target the cancer, the tumour microenvironment, or both. Current guidelines recommend targe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Unverzagt, Susanne, Moldenhauer, Ines, Nothacker, Monika, Roßmeißl, Dorothea, Hadjinicolaou, Andreas V, Peinemann, Frank, Greco, Francesco, Seliger, Barbara
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Soggetti:
Medicine General & Introductory Medical Sciences
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484451/
https://ncbi.nlm.nih.gov/pubmed/28504837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011673.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi